![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
S/GSK1265744: A Next Generation Integrase Inhibitor (INI) with Activity Against Raltegravir-Resistant Clinical Isolates
|
|
|
Reported by Jules Levin
18th Intl AIDS Conference, July 18-23 2010 Vienna
1Mark R Underwood, 1Marty St Clair, 1Brian A Johns, 2Akihiko Sato, 2Tamio Fujiwara, 1William Spreen
1GlaxoSmithKline Inc., RTP, NC, United States; 2Shionogi & CO., LTD., Osaka, Japan
![](../images/072110/072110-3/image002.gif)
![](../images/072110/072110-3/image004.gif)
![](../images/072110/072110-3/image006.gif)
![](../images/072110/072110-3/image008.gif)
![](../images/072110/072110-3/image010.gif)
![](../images/072110/072110-3/image012.gif)
![](../images/072110/072110-3/image014.gif)
![](../images/072110/072110-3/image016.gif)
![](../images/072110/072110-3/image018.gif)
![](../images/072110/072110-3/image020.gif)
![](../images/072110/072110-3/image022.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|